About David Wu, MD, PhD
Dr. David Wu is a retina surgeon and researcher at Mass. Eye and Ear. His primary practice is located at Mass. Eye and Ear, Longwood at 800 Huntington Avenue in Boston. He also sees patients at the main Mass. Eye and Ear campus at 243 Charles Street. He treats patients with vitreoretinal diseases, including diabetic retinopathy, macular degeneration, retinal detachments, retinal vascular occlusions, macular holes, epiretinal membranes, and vitreomacular traction. Dr. Wu also is an active participator in the Diabetic Teleretinal Screening Program at Mass. Eye and Ear.
Dr. Wu was a member of the selective Inteflex BS/MD program at the University of Michigan (UM). He earned both an MD with distinction in research and a PhD in Neuroscience. After medical school, he completed his ophthalmology residency at the UM W.K. Kellogg Eye Center where he won the George Slocum and James M. LaBerge awards for research as well as the Walter R. Parker teaching award. After residency, he was named a Heed Fellow and completed a Medical Retinal and Research fellowship at UM. Next, he completed subspecialty training in vitreoretinal surgery at the Doheny Eye Institute, Keck School of Medicine at the University of South California where he won an Excellence in Teaching award. He joined the faculty at Mass. Eye and Ear in July 2012.
Clinical Interests:
- Diabetic retinopathy
- Epiretinal membrane
- Macular degeneration
- Macular holes
- Retina
- Retinal Detachment
- Retinal vascular occlusive diseases
Treats:
- Adult
Locations
Mass Eye and Ear at Longwood
800 Huntington Ave.
Boston, MA 02115
Phone: 617-936-6160
Medical Education
- PhD, University of Michigan
- MD, University of Michigan Medical School
- Residency, University of Michigan Kellogg Eye Center
- Fellowship, Kellogg Eye Center
- Fellowship, USC/Doheny Eye Institute
American Board Certifications
- Ophthalmology, American Board of Ophthalmology
Research
Dr. Wu is performing transcriptome profiling on photoreceptors from healthy and degenerating retinas. His goal is to characterize molecular pathways of retinal disease and identify novel mechanisms that may be targeted to slow photoreceptor loss. Dr. Wu also sees vitreoretinal surgery patients at Mass. Eye and Ear's Longwood and Charles Street locations.
Publications
-
Chincore Y, Begaj T, Wu D, Drokhlyansky E, Cepko CL. Glycolytic reliance promotes anabolism in photoreceptors. Elife. 6. pii: e25946. 2017.
Finn AP, Eliott D, Kim LA, Husain D, Wu DM, Young LH, Kim IK, Andreoli C, Skonda D, Vavvas DG, Miller JB. Characteristics and Outcomes of Simultaneous Bilateral Rhegmatogenous Retinal Detachments. OSLI Retina. 47(9): 840-845. 2016.
Zhang T, Wu DM, Xu G, Puro DG. The electrotonic architecture of the retinal microvasculature: modulation by angiotensin II. J Physiol. 589(9): 2383-2399. 2011.
Matsushita K, Fukumoto M, Kobayashi T, Kobayashi M, Ishikazi E, Minami M, Katsumura K, Liao SD, Wu DM, Zhang T, Puro DG. Diabetes-induced inhibition of voltage-dependent calcium channels in the retinal microvasculature: role of spermine. IOVS. 51(11): 5979-5990. 2010.
Reviews: Comments and Ratings
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.